The KIC, co-hosted by the National Clinical Trial Support Foundation (KoNECT), the Ministry of Health and Welfare, and the Ministry of Food and Drug Safety, is the first offline event since COVID-19 was held non-face-to-face.
JNPMEDI, which is known as a domestic leader in Decentralized Clinical Trial (DCT), which is emerging as a trend, will participate in the event to meet various companies and actively promote products based on digital transformation cases of clinical trial data management.
Meanwhile, 2022 KIC, which marks its eighth anniversary this year, is Asia's largest clinical trial conference attended by about 250 companies and institutions, including domestic and foreign bio-experts, pharmaceutical company developers, clinical researchers, regulators, clinical trial trust agencies and clinical experts.
Details of the conference can be found on the event's website, and JNPMEDI's booth B8 will be located in the Park Ballroom on the 5th floor.